← Leaderboards
Biplab Dasgupta
Cincinnati Childrens Hosp Med Ctr
$8,405,387
Attributed
$8,405,387
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,405,387 · 4
By mechanism
R01$8,405,387 · 4
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Senthilkumar Sadhasivam$17,658,675
Others in their field
Top investigators on “Novel Therapeutics”
- David Heimbrook · Leidos Biomedical Research, Inc.$355,066,875
- Judith S. Currier · University Of California Los Angeles$321,442,024
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
- Daniel R Kuritzkes · Brigham And Women'S Hospital$246,024,897
- Sharon A Nachman · Johns Hopkins University$212,395,175
Research focus
Novel TherapeuticsIn VivoMolecularPharmaceutical PreparationsStem CellsGenesTumor GrowthDoseTumorMalignant NeoplasmsCell LineResistanceMouse ModelGeneticMetabolomicsCellsIn VitroGlioblastomaThe Cancer Genome AtlasMessenger RnaTissuesGrowthAdenylate KinaseMutation
Grant awards (23)
Mechanisms of Biguanide Sensitivity in GBM$455,864
R01 · FY2025 · NS · contact PI
ATIC is a novel molecular target in diffuse intrinsic pontine glioma$420,186
R01 · FY2025 · NS · contact PI
Mechanisms of Biguanide Sensitivity in GBM$457,943
R01 · FY2024 · NS · contact PI
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges$412,828
R01 · FY2024 · NS · contact PI
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges$6,595
R01 · FY2024 · NS · contact PI
Mechanisms of Biguanide Sensitivity in GBM$1
R01 · FY2024 · NS · contact PI
ATIC is a novel molecular target in diffuse intrinsic pontine glioma$484,167
R01 · FY2023 · NS · contact PI
Mechanisms of Biguanide Sensitivity in GBM$472,108
R01 · FY2023 · NS · contact PI
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges$432,394
R01 · FY2023 · NS · contact PI
Mechanisms of Biguanide Sensitivity in GBM$504,183
R01 · FY2022 · NS · contact PI
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges$432,394
R01 · FY2022 · NS · contact PI
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges$461,828
R01 · FY2021 · NS · contact PI
Biguanide Sensitivity of Glioma Stem Cells$341,398
R01 · FY2021 · NS · contact PI
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges$476,578
R01 · FY2020 · NS · contact PI
Biguanide Sensitivity of Glioma Stem Cells$341,398
R01 · FY2020 · NS · contact PI
Biguanide Sensitivity of Glioma Stem Cells$341,398
R01 · FY2019 · NS · contact PI
Biguanide Sensitivity of Glioma Stem Cells$347,104
R01 · FY2018 · NS · contact PI
Biguanide Sensitivity of Glioma Stem Cells$347,942
R01 · FY2017 · NS · contact PI
Regulation of Forebrain Neurogenesis by the Energy Sensor AMP Kinase$334,688
R01 · FY2016 · NS · contact PI
Regulation of Forebrain Neurogenesis by the Energy Sensor AMP Kinase$334,688
R01 · FY2015 · NS · contact PI
Regulation of Forebrain Neurogenesis by the Energy Sensor AMP Kinase$331,340
R01 · FY2014 · NS · contact PI
Regulation of Forebrain Neurogenesis by the Energy Sensor AMP Kinase$322,531
R01 · FY2013 · NS · contact PI
Regulation of Forebrain Neurogenesis by the Energy Sensor AMP Kinase$345,831
R01 · FY2012 · NS · contact PI